Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: An observational study

This study suggests that intravaginal CO2-laser therapy for postmenopausal women with clinical signs and symptoms of GSM may be effective in improving both vaginal pathophysiology and reported symptoms.